US Bancorp’s Generate Biomedicines GENB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.85K Buy
+190
New +$2.92K ﹤0.01% 3846

Other funds holding GENB

US Bancorp's GENB Position: Q3 2026 in Review

US Bancorp opened a new position in Generate Biomedicines (GENB) in Q3 2026: 190 shares worth $2.85K. The stake represents ﹤0.01% of the portfolio and ranks #3846 among its holdings.

109 funds tracked by Wall St. Rank hold GENB as of Q3 2026.

  • US Bancorp held 190 shares of Generate Biomedicines worth $2.85K as of Q3 2026.
  • Generate Biomedicines was a new US Bancorp position in Q3 2026.
  • Generate Biomedicines made up ﹤0.01% of US Bancorp's portfolio in Q3 2026, its #3846 holding.
  • 109 funds tracked by Wall St. Rank held Generate Biomedicines as of Q3 2026.

Based on US Bancorp's 13F filing for Q3 2026, filed 5 Nov 2026.